Novo Nordisk
NVO
NVO
1,144 hedge funds and large institutions have $22.1B invested in Novo Nordisk in 2023 Q1 according to their latest regulatory filings, with 175 funds opening new positions, 327 increasing their positions, 427 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,144
Holders Change
+98
Holders Change %
+9.37%
% of All Funds
18.31%
Holding in Top 10
56
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+21.74%
% of All Funds
0.9%
New
175
Increased
327
Reduced
427
Closed
53
Calls
$296M
Puts
$228M
Net Calls
+$68.1M
Net Calls Change
-$41.4M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$565M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$181M |
| 3 |
Jennison Associates
New York
|
+$141M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$129M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$74.3M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$403M |
| 2 |
Renaissance Technologies
New York
|
-$287M |
| 3 |
Millennium Management
New York
|
-$242M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$183M |
| 5 |
Morgan Stanley
New York
|
-$97M |
